Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers

Table 1 Patient characteristics

	Lansoprazole group (n = 45)	Rebamipide group (n = 45)	P-value
Age (yr)(mean ± SD, median)	70 ± 7.8, 72	67 ± 8.0, 67	0.0930
Gender (M/F)	36/9	31/14	0.2269
H. pylori-infection	86.7%	84.4%	0.7643
Smoker	31.1%	33.3%	0.8215
Drinking alcohol	46.7%	42.2%	0.6714
History of disease	46.7%	31.1%	0.1301
Complicated disease	71.1%	71.1%	1.0000
Location of tumors			0.1620
Low	23	16
Middle	17	26
Upper	5	3
Tumor size			0.4986
> 20 (mm)	13	16
≤ 20 (mm)	32	29
Histologic classification			0.6939
Tub1	41	42
Tub2	4	3
Dissected size (mean ± SD, mm)	30.5 ± 7.8	30.6 ± 6.4	0.9413
Dissected area (mean ± SD, mm2)	687.9 ± 393.1.7	712.3 ± 298.6	0.7417
Glandular atrophy			0.3167
C-1	0	0
C-2	3	2
C-3	11	14
O-1	19	13
O-2	12	13
O-3	0	3
CandO			0.6547
C	14	16
O	31	29
Intestinal metaplasia	71.1%	68.9%	0.8181

H. pylori: Helicobacter pylori; M/F: Male/female.